Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Neurogene
535 W 24th Street, 5th Floor
New York, NY 10011
Phone: 646-921-0610
https://www.neurogene.com/

Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies.

Key Contact
Name
Rachel McMinn
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
12/16/20 $115,000,000 Series B Alexandria Venture Investments
ArrowMark Partners
Avidity Partners
BlackRock
Casdin Capital
Cormorant Asset Management
EcoR1 Capital
Janus Henderson Investors
Redmile Group
Samsara BioCapital
undisclosed


Featured Reading